EIBALL Session - Jointly organised by the EIBALL and QIBA
EIBALL 7 - Lung cancer screening: implementing quantitative imaging biomarker protocols
Lectures
1
Chairperson's introduction
05:00Aad Van Der Lugt, Rotterdam / NL
2
Status of lung cancer screening in Europe
15:00Torsten Gerriet Blum, Berlin / DE
3
Protocol and quality control programmes in European lung cancer screening programmes
15:00Hans-Ulrich Kauczor, Heidelberg / DE
4
QIBA profile on small lung nodule volume assessment and monitoring in low-dose CT
15:00Gudrun Zahlmann, Oak Brook / US
5
Panel discussion: How can we accelerate the implementation of robust QA programmes in lung cancer screening?
10:00Panel discussion: How can we accelerate the implementation of robust QA programmes in lung cancer screening?
5 min
Chairperson's introduction
Aad Van Der Lugt, Rotterdam / Netherlands
15 min
Status of lung cancer screening in Europe
Torsten Gerriet Blum, Berlin / Germany
1. To learn about the status of the EU's lung cancer screening programme decision and plans to implement it in the 27 member states.
2. To appreciate all the necessary contributors for successfully implementing national screening programmes.
3. To understand the scope and challenges that are coming with the implementation of lung cancer screening in Europe.
2. To appreciate all the necessary contributors for successfully implementing national screening programmes.
3. To understand the scope and challenges that are coming with the implementation of lung cancer screening in Europe.
15 min
Protocol and quality control programmes in European lung cancer screening programmes
Hans-Ulrich Kauczor, Heidelberg / Germany
1. To learn the specifics of imaging protocols and QA programmes necessary to benefit all European citizens eligible for lung cancer screening.
2. To appreciate ESR's role in planning and implementing screening programmes in the respective member states.
3. To understand in detail the imaging solutions and challenges of the lung cancer screening QA programme.
2. To appreciate ESR's role in planning and implementing screening programmes in the respective member states.
3. To understand in detail the imaging solutions and challenges of the lung cancer screening QA programme.
15 min
QIBA profile on small lung nodule volume assessment and monitoring in low-dose CT
Gudrun Zahlmann, Oak Brook / United States
1. To learn how to implement imaging procedures to make lung nodule volumetric assessments reliable and reproducible.
2. To appreciate imaging centres' critical role and responsibilities in performing low-dose CT imaging for screening.
3. To understand which devices and personnel are needed and what performance measures are required to achieve reliable and reproducible nodule assessments.
2. To appreciate imaging centres' critical role and responsibilities in performing low-dose CT imaging for screening.
3. To understand which devices and personnel are needed and what performance measures are required to achieve reliable and reproducible nodule assessments.
10 min
Panel discussion: How can we accelerate the implementation of robust QA programmes in lung cancer screening?